Over 7,500 medications in stock!
100% Original medicines of Russian and world brands
Fast international shipping and delivery!
Free shipping order $150
24/7 Customer support

METORTRIT™ injection solution 10mg/ml (2ml), syringes 1pc

🔥 7 items sold in last 3 hours
10 people are viewing this product
Brand:
Active Ingredient:

Manufacturer:

$78.0

or
Buy from 5 to 10 items and get 2% OFF
on each product
Buy from 11 to 30 items and get 5% OFF
on each product
Buy from 31 to 100 items and get 10% OFF
on each product
Buy from 101 to ∞ items and get 15% OFF
on each product

All forms of

METORTRIT™ injection solution 10mg/ml (1.25ml), syringe 1pc

$60.0
Add to cart

METORTRIT™ injection solution 10mg/ml (1.5ml), syringes 1pc

$74.0
Add to cart

Analogs of METORTRIT™

METOJECT™ solution for subcutaneous injection 50mg/ml (0.25ml), syringes 1pc

$50.0
Add to cart

METOJECT™ solution for subcutaneous injection 50mg/ml (0.4ml), syringes 1pc

$70.0
Add to cart

METOJECT™ solution for subcutaneous injection 50mg/ml (0.5ml), syringes 1pc

$86.0
Add to cart

METOJECT™ solution for subcutaneous injection 50mg/ml (0.15ml), syringes 1pc

$41.0
Add to cart

Table of Contents

METORTRIT™ 10mg Solution 2ml Buy Online

METORTRIT Injection Solution: A Comprehensive Overview

Managing chronic inflammatory conditions can be challenging, but advancements in medicine offer new avenues for relief. METORTRIT injection solution provides a targeted approach to managing these conditions. This overview explores its key aspects, providing valuable insight for healthcare professionals and patients alike.

What is METORTRIT?

METORTRIT injection solution is a antineoplastic and immunomodulatory agent, specifically a folate analog anti-metabolite. Its active ingredient, methotrexate, works by interfering with the processes crucial for cell growth and replication, making it effective in treating various conditions characterized by rapid cell proliferation.

The medication is primarily known for its use in managing rheumatoid arthritis and certain inflammatory skin conditions like psoriasis. Its mechanism of action involves inhibiting the enzyme dihydrofolate reductase, thus disrupting DNA synthesis and ultimately slowing down the inflammatory response. This targeted approach minimizes damage to healthy cells while effectively addressing the underlying causes of inflammation.

Available as a pre-filled syringe for convenient administration, METORTRIT offers a precise and controlled method of delivering methotrexate. This precise dosage ensures optimal therapeutic efficacy while minimizing the risk of adverse effects. The formulation is designed for various routes of administration, as determined by the prescribing physician based on individual patient needs and the specific condition being treated. Careful consideration of dosage and administration is essential for safe and effective use.

Importantly, METORTRIT, like other medications containing methotrexate, should only be used under strict medical supervision. Regular monitoring of blood counts and other relevant parameters is crucial to ensure patient safety and to detect potential side effects early. The physician will carefully assess the patient’s overall health and medical history to determine suitability and to adjust the dosage as needed throughout the course of treatment. This close collaboration ensures the best possible outcome while minimizing potential risks.

Therapeutic Applications of METORTRIT

METORTRIT’s primary therapeutic applications stem from its potent anti-inflammatory and immunomodulatory properties, making it a valuable tool in managing a range of challenging conditions. Its effectiveness lies in its ability to selectively target and suppress the overactive immune responses that characterize many chronic inflammatory diseases.

A significant area of application is in the treatment of rheumatoid arthritis (RA), a debilitating autoimmune disease causing joint pain, swelling, and stiffness. METORTRIT helps to alleviate these symptoms by reducing inflammation and slowing the progression of joint damage. Its use in RA often involves careful monitoring of disease activity and potential side effects, ensuring optimal therapeutic benefit with minimized risk.

Furthermore, METORTRIT proves efficacious in the management of certain severe forms of psoriasis, a chronic inflammatory skin condition marked by red, scaly patches. By modulating the immune system’s response, it helps to control the disease’s progression, reducing the severity and frequency of flares. Individual responses to treatment can vary, however, and close monitoring is crucial for effective management.

In addition to its established roles in RA and psoriasis, METORTRIT may also find application in other inflammatory conditions, though further research may be necessary to fully define its scope of use in these areas. Always consult with a healthcare professional to determine if METORTRIT is an appropriate treatment option for your specific needs and condition, as well as to discuss potential risks and benefits.

The precise therapeutic approach with METORTRIT, including dosage and administration route, is tailored by the physician to each patient’s unique circumstances and disease characteristics. This personalized approach ensures the most effective and safest treatment strategy. The physician will conduct regular follow-up appointments to monitor progress and make necessary adjustments to the treatment plan as needed.

Mechanism of Action

METORTRIT’s therapeutic effects are intricately linked to its active component, methotrexate, a folate antagonist. Methotrexate’s primary mechanism involves competitively inhibiting the enzyme dihydrofolate reductase (DHFR). This inhibition disrupts the synthesis of purines and pyrimidines, essential building blocks of DNA and RNA, thereby halting cell replication and growth.

The impact on rapidly dividing cells, such as those involved in inflammation and immune responses, is particularly significant. By disrupting the cellular processes crucial for proliferation, methotrexate effectively dampens the inflammatory cascade, leading to symptom relief in conditions like rheumatoid arthritis and psoriasis. This targeted action minimizes harm to healthy cells while effectively controlling the disease process.

Beyond its direct effect on cell replication, methotrexate also exhibits immunomodulatory actions. It influences the activity of various immune cells, including T lymphocytes, reducing their inflammatory output. This dual mechanism – disrupting cell growth and modulating immune responses – contributes to METORTRIT’s efficacy in treating a range of inflammatory conditions. The precise effects are complex and depend upon the specific condition, dosage, and individual patient response.

It’s crucial to understand that the detailed mechanisms by which methotrexate exerts its therapeutic effects are still being investigated. The interplay between its effects on cell proliferation and immune modulation is complex and likely involves multiple pathways and interactions. Ongoing research continues to shed light on the intricacies of methotrexate’s action, further refining our understanding of its therapeutic potential and optimizing its clinical application. This ongoing research is key to improving patient outcomes and managing potential side effects.

Administration and Dosage

METORTRIT injection solution is administered parenterally, meaning it’s given outside the gastrointestinal tract. The specific route of administration—subcutaneous, intramuscular, or intravenous—is determined by the physician based on individual patient needs and the condition being treated. Careful adherence to the prescribed route and technique is crucial for optimal efficacy and safety.

Dosage regimens are highly individualized and depend on several factors, including the patient’s specific condition, overall health, and response to treatment. The physician carefully considers these factors to determine the appropriate starting dose and subsequent adjustments. Regular monitoring of treatment response and potential side effects is critical for safe and effective management.

Initial doses are generally lower, gradually increasing as tolerated to achieve the desired therapeutic effect. This titration approach allows for careful monitoring of any adverse reactions while optimizing the benefits of treatment. The physician will closely monitor the patient’s progress and adjust the dosage accordingly throughout the course of therapy. This personalized approach ensures the most effective treatment strategy while minimizing risks.

It is imperative that METORTRIT is administered only by or under the direct supervision of a healthcare professional experienced in administering methotrexate. Improper administration can lead to complications, emphasizing the importance of precise technique and careful monitoring. The physician will provide detailed instructions on the proper administration technique and provide guidance on managing potential side effects. Patient education and adherence to the prescribed regimen are essential for achieving positive outcomes.

Potential Side Effects

While METORTRIT offers significant therapeutic benefits, it’s crucial to be aware of potential side effects. These can range from mild to severe, and their occurrence and severity vary considerably depending on the individual, dosage, and duration of treatment. Close monitoring by a healthcare professional is essential to manage any adverse reactions effectively.

Common side effects can include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. These are often mild and may resolve spontaneously or with supportive measures. Less frequent but more serious side effects may involve the bone marrow, potentially leading to decreased blood cell counts (leukopenia, thrombocytopenia, anemia). Regular blood tests are vital to monitor these parameters.

Other potential side effects can include liver toxicity, manifested by elevated liver enzymes, and kidney dysfunction. These require careful monitoring through regular blood work and may necessitate dose adjustments or temporary treatment interruption. Infections may also occur more frequently due to the medication’s immunosuppressive effects, highlighting the importance of prompt medical attention for any signs of infection.

Serious, though rare, side effects can involve pulmonary complications, such as pneumonitis. Immediate medical attention is necessary if symptoms such as shortness of breath or chest pain arise. Allergic reactions, ranging from mild skin rashes to severe anaphylaxis, are also possible. Patients should be alert for any signs of an allergic reaction and seek prompt medical care if they occur. Open communication with your physician is crucial for managing any side effects and ensuring safe and effective treatment.

Pros

METORTRIT offers several advantages in the management of inflammatory conditions. Its targeted mechanism of action allows for effective symptom control while minimizing potential harm to healthy cells. This targeted approach is crucial for long-term disease management and improves overall quality of life.

The injectable formulation provides a precise and controlled method of drug delivery, ensuring consistent therapeutic levels are achieved. This precise delivery is essential for optimizing treatment efficacy and minimizing the risk of adverse effects related to inconsistent dosing. The pre-filled syringes further enhance convenience and reduce the risk of medication errors during administration.

For many patients, METORTRIT provides significant relief from the debilitating symptoms of rheumatoid arthritis and severe psoriasis. This symptom relief can dramatically improve daily functioning, allowing individuals to participate more fully in their work, social activities, and personal lives. The improvement in quality of life is a significant benefit for those suffering from these often chronic conditions.

While individual responses vary, many patients experience a substantial reduction in disease activity and a marked improvement in their overall health. This positive impact on disease progression can significantly impact long-term outcomes and improve overall prognosis. The ability to effectively manage symptoms and disease progression offers patients renewed hope and improved quality of life.

Cons

Despite its therapeutic benefits, METORTRIT carries potential drawbacks that necessitate careful consideration and monitoring. The most significant concern revolves around the risk of serious adverse events, including bone marrow suppression, liver toxicity, and kidney damage. Regular blood tests are crucial to detect these complications early.

Gastrointestinal side effects, such as nausea, vomiting, and diarrhea, are relatively common. While often manageable, these effects can significantly impact a patient’s quality of life, particularly if severe. Strategies to mitigate these side effects, such as taking the medication with food or adjusting the dosage, may be necessary.

The need for close medical supervision is a crucial consideration. Regular monitoring of blood counts, liver function, and kidney function is essential to ensure the safe and effective use of METORTRIT. This ongoing monitoring requires frequent visits to the healthcare provider, potentially impacting the patient’s time and resources.

Furthermore, the potential for interactions with other medications necessitates careful assessment of a patient’s overall medication regimen. The physician must carefully review all medications to identify and mitigate any potential drug interactions that could lead to adverse effects. This careful review is crucial for safe and effective treatment, maximizing benefits while minimizing risks.

Contraindications and Precautions

METORTRIT is contraindicated in several situations, emphasizing the importance of a thorough medical evaluation before initiating treatment. Pregnant or breastfeeding women should absolutely avoid METORTRIT due to the potential for severe harm to the fetus or infant. Individuals with pre-existing liver disease, kidney disease, or bone marrow suppression should also not use this medication due to the risk of exacerbating these conditions.

Patients with compromised immune systems should exercise extreme caution when considering METORTRIT, as its immunosuppressive effects could further weaken their defenses against infection. A careful assessment of the risks and benefits is crucial in such cases. The physician must weigh the potential therapeutic advantages against the heightened risk of opportunistic infections.

Before starting METORTRIT, patients should inform their physician about all current medications, including over-the-counter drugs and herbal supplements. This comprehensive medication review is essential to identify and manage potential drug interactions that could compromise safety or efficacy. The physician will carefully assess the potential for interactions and adjust the treatment plan as needed.

Alcohol consumption should be minimized or avoided entirely during METORTRIT therapy, as it can exacerbate liver toxicity. Similarly, patients should be advised to avoid exposure to potential sources of infection, including crowds and individuals with known illnesses. These precautions are crucial in mitigating the risk of complications associated with the medication’s immunosuppressive effects. Adherence to these guidelines is essential for safe and effective treatment.

Monitoring and Follow-up

Regular monitoring is paramount throughout METORTRIT therapy to ensure patient safety and optimize treatment efficacy. This involves careful observation for any signs or symptoms of adverse effects, coupled with routine laboratory testing to assess key parameters. The frequency of monitoring is determined by the physician based on individual patient needs and the severity of the condition being treated.

Complete blood counts (CBCs) are essential to monitor for bone marrow suppression, a potential side effect of methotrexate. These tests assess the levels of red blood cells, white blood cells, and platelets, providing valuable insights into the health of the bone marrow. Liver function tests (LFTs) and kidney function tests (KFTs) are also crucial, assessing the potential for liver and kidney toxicity.

The frequency of these tests can vary, but generally, CBCs, LFTs, and KFTs are performed before initiating treatment, at regular intervals during therapy, and as clinically indicated. The physician will interpret the results of these tests to make appropriate adjustments to the treatment plan, ensuring that the benefits of treatment outweigh potential risks. Any significant deviations from normal ranges may necessitate dose reductions, temporary treatment interruptions, or even discontinuation of therapy.

Beyond laboratory testing, regular clinical assessments are also vital. The physician will evaluate the patient’s response to treatment, assessing symptom control and overall well-being. This ongoing dialogue between patient and physician is essential for making informed decisions about the course of therapy, adjusting the treatment plan as needed, and ensuring optimal outcomes. Open communication between the patient and their healthcare provider is key to successful treatment and effective management of potential side effects.

  • Metortrit™ Injection Solution 10Mg/Ml (2Ml), Syringes 1Pc Buy Online 2
    [Author]

    Georgia Austin is a seasoned SEO content writer, editor, and content marketing strategist with over 7 years of experience crafting compelling copy for leading brands in the healthcare and pharmaceutic...

    View all posts
  • Metortrit™ Injection Solution 10Mg/Ml (2Ml), Syringes 1Pc Buy Online 4
    [Editor]

    Jonathan Brown is a seasoned professional editor, researcher, and educator with over 12 years of experience helping authors find their voice and polish their writing. As a content editor for RxPulsar....

    View all posts
  • Metortrit™ Injection Solution 10Mg/Ml (2Ml), Syringes 1Pc Buy Online 6
    [Medical reviewer]

    Dr. Jessica Kerns is a highly accomplished pediatrician and adolescent medicine specialist who serves as a clinical instructor in the Department of Pediatrics at the Icahn School of Medicine at Mount...

    View all posts

Reviews

There are no reviews yet.

Be the first to review “METORTRIT™ injection solution 10mg/ml (2ml), syringes 1pc”

Your email address will not be published. Required fields are marked

Similar products

LESTRODEX™ tablets 2.5mg, 30pcs

$134.0
Add to cart

LETROZOLE tablets 2.5mg, 30pcs

$519.0
Add to cart

CARBOPLATIN-RONC™ concentrate for infusion solution 10mg/ml (45ml), vial 1pc

$158.0
Add to cart

CAPECITABINE tablets 500mg, 120pcs

$530.0
Add to cart

CABOMETYX™ tablets 20mg, 30pcs

$25,072.0
Add to cart

IRITEN™ concentrate for infusion solution 20mg/ml (5ml), vial 1pc

$195.0
Add to cart

IRINOTECAN-TEVA™ concentrate for infusion solution 20mg/ml (2ml), vial 1pc

$100.0
Add to cart

IMFINZI™ concentrate for infusion solution 50mg/ml (10ml), vial 1pc

$10,270.0
Add to cart

IMATINIB tablets 100mg, 30pcs

$163.0
Add to cart

ZOLADEX™ implant 10.8mg, syringe applicators 1pc

$854.0
Add to cart

ZARSIO™ solution for IV and SC injection 48 million IU/0.5ml (0.5ml), syringes 5pcs

$1,273.0
Add to cart

DOCETAXEL SANDOZ™ concentrate for infusion solution 10mg/ml (16ml), vial 1pc

$898.0
Add to cart

DOCETAXEL SANDOZ™ concentrate for infusion solution 10mg/ml (2ml), vial 1pc

$150.0
Add to cart

HERCEPTIN™ lyophilisate for concentrate for infusion solution 150mg, vial 1pc

$670.0
Add to cart

HERCEPTIN™ lyophilisate for concentrate for infusion solution 440mg + solvent 20ml, vial 1pc

$1,945.0
Add to cart

HYDREA™ capsules 500mg, 20pcs

$16.0
Add to cart

VINBLASTIN-LENS™ lyophilisate for IV infusion 5mg, vial 1pc

$27.0
Add to cart

BLINCYTO™ lyophilisate for concentrate for infusion solution 35mcg+stabilizer, vial 1pc

$11,119.0
Add to cart

BICALUTAMIDE tablets 150mg, 30pcs

$151.0
Add to cart

BIKANA™ tablets 50mg, 28pcs

$53.0
Add to cart

BAVENCIO™ concentrate for infusion solution 20mg/ml (10ml), vial 1pc

$3,690.0
Add to cart

ARFLEIDA™ concentrate for infusion solution 25mg/ml (4ml), 1 vial

$7,437.0
Add to cart

ANAZALES™ tablets 1mg, 28pcs

$73.0
Add to cart

AVASTIN™ concentrate for infusion solution 25mg/ml (400mg/16ml), vial 16ml 1pc

$2,272.0
Add to cart
Select your currency